UnitedHealth Group Incorporated $UNH Stake Lessened by MFF Capital Investments Ltd

MFF Capital Investments Ltd reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 235,981 shares of the healthcare conglomerate’s stock after selling 6,403 shares during the quarter. UnitedHealth Group comprises approximately 5.7% of MFF Capital Investments Ltd’s portfolio, making the stock its 9th largest holding. MFF Capital Investments Ltd’s holdings in UnitedHealth Group were worth $86,624,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Montaka Global Pty Ltd acquired a new stake in shares of UnitedHealth Group during the third quarter worth about $5,506,000. Keybank National Association OH lifted its holdings in shares of UnitedHealth Group by 7.2% in the 3rd quarter. Keybank National Association OH now owns 197,486 shares of the healthcare conglomerate’s stock valued at $72,493,000 after purchasing an additional 13,241 shares during the last quarter. Csenge Advisory Group boosted its position in shares of UnitedHealth Group by 17.7% in the 3rd quarter. Csenge Advisory Group now owns 7,412 shares of the healthcare conglomerate’s stock valued at $2,721,000 after purchasing an additional 1,115 shares during the period. Cassia Capital Partners LLC grew its stake in UnitedHealth Group by 3.3% during the 3rd quarter. Cassia Capital Partners LLC now owns 3,551 shares of the healthcare conglomerate’s stock worth $1,304,000 after buying an additional 114 shares during the last quarter. Finally, D Orazio & Associates Inc. increased its position in UnitedHealth Group by 0.4% during the third quarter. D Orazio & Associates Inc. now owns 49,062 shares of the healthcare conglomerate’s stock worth $18,010,000 after buying an additional 178 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on UNH. Zacks Research cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 14th. BMO Capital Markets set a $512.00 price objective on UnitedHealth Group in a research report on Tuesday, July 21st. Mizuho lifted their target price on UnitedHealth Group from $493.00 to $500.00 and gave the company an “outperform” rating in a research note on Thursday, October 22nd. New Street Research set a $402.00 target price on UnitedHealth Group in a report on Friday, October 9th. Finally, TD Cowen restated a “hold” rating and set a $402.00 price target on shares of UnitedHealth Group in a research note on Thursday, October 15th. Twenty equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $463.93.

UnitedHealth Group Trading Up 1.8%

NYSE:UNH opened at $404.88 on Wednesday. The stock has a fifty day moving average price of $390.98 and a two-hundred day moving average price of $364.53. The stock has a market capitalization of $362.78 billion, a price-to-earnings ratio of 23.12, a PEG ratio of 1.44 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same period in the previous year, the firm earned $2.59 EPS. The business’s revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be paid a $2.32 dividend. The ex-dividend date is Monday, December 7th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth’s profits are reportedly improving despite fewer members and lower Optum Health sales, with higher margins and pricing discipline supporting the recovery. Medical-cost pressures remain a risk. Article: Leaner and Meaner: Are UNH’s Profits Getting Bigger?
• Neutral Sentiment: Madeline Bell, former CEO of Children’s Hospital of Philadelphia, joined UnitedHealth’s board. Her healthcare leadership adds experience, though the appointment alone may have limited near-term earnings impact. Article: Madeline Bell Joins UnitedHealth Group Board of Directors
• Neutral Sentiment: A proposed bill would give some ACA marketplace customers a special enrollment period if their provider leaves a plan’s network. It is not enacted, and the potential effect on UNH is uncertain. Article: Right to Re-Enroll Act of 2026
• Negative Sentiment: UnitedHealth plans to drop Medicare coverage in 140 counties and leave Wyoming. The pullback could reduce membership and revenue in affected markets, although exiting areas with unfavorable economics may help control costs. Article: UnitedHealth Group Will Drop Medicare Plans In 140 Counties And Leave Wyoming

Insider Buying and Selling

In related news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.19% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.